Silica-Gentamicin Nanohybrids: Synthesis and Antimicrobial Action.

ABSTRACT: Orthopedic applications commonly require the administration of systemic antibiotics. Gentamicin is one of the most commonly used aminoglycosides in the treatment and prophylaxis of infections associated with orthopedic applications, but gentamicin has a short half-life. However, silica nanoparticles (SiO? NPs) can be used as elegant carriers for antibiotics to prolong their release. Our goal is the preparation and characterization of SiO?-gentamicin nanohybrids for their potential antimicrobial administration in orthopedic applications. In vitro gentamicin release profile from the nanohybrids (gentamicin-conjugated SiO? NPs) prepared by the base-catalyzed precipitation exhibited fast release (21.4%) during the first 24 h and further extension with 43.9% release during the five-day experiment. Antimicrobial studies of the SiO?-gentamicin nanohybrids versus native SiO? NPs and free gentamicin were performed against Bacillus subtilis (B. subtilis), Pseudomonas fluorescens (P. fluorescens) and Escherichia coli (E. coli). SiO?-gentamicin nanohybrids were most effective against B. subtilis. SiO? NPs play no antimicrobial role. Parallel antimicrobial studies for the filter-sterilized gentamicin were performed to assess the effect of ultraviolet (UV)-irradiation on gentamicin. In summary, the initial fast gentamicin release fits the need for high concentration of antibiotics after orthopedic surgical interventions. Moreover, the extended release justifies the promising antimicrobial administration of the nanohybrids in bone applications.

SUBMITTER: Mosselhy DA 

PROVIDER: S-EPMC5456682 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature